If you liked this article you might like

Mallinckrodt's Top Drug Could Go the Way of EpiPen
Cramer: The Stock Market Is Helping the Consumer This Year
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
Crude Oil, Health Care Team Up to Pull Wall Street Lower